Liqiang Yang

Liqiang Yang is an experienced executive in the biotechnology and pharmaceutical industry, with a background in statistics. Currently serving as Executive VP at 上海快序生物科技公司 and Chief Strategy Officer at Rapid Novor Inc. Previously held positions at Tocagen Inc., Pfizer, Amgen, Scirex, and SPSS, with a focus on oncology clinical development. Holds a Ph.D. in Statistics from North Carolina State University and a B.S. in Mathematics from Peking University.